Zhejiang Xianju Pharmaceutical Co.,Ltd.

002332.SZ

002332.SZZhejiang Xianju Pharmaceutical Co.,Ltd. CN flag

Shenzhen

9.32

CNY

-0.04

(-0.43%)

0.39EPS

23.90P/E

9.22BMarket Cap

Apr 23Next Earn

Upgrade to Unlock Non-US CompaniesTo view real-time data and analysis of companies outside of the United States, upgrade your account to our premium subscription.

Upgrade

ISIN

CNE100000K64

Return %

Stock

S&P500

-24.10

12.14

-0.32

46.67

-35.72

105.92

Use logarithmic scale

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	TTM
Revenue per Share	2.57	3.06	3.2	3.1	2.74	3.18	3.97	4.07	4.38	4.41	4.43	4.17	4.03	4.02
Basic EPS, GAAP	0.16	0.08	0.07	0.13	0.16	0.23	0.33	0.45	0.55	0.63	0.76	0.57	0.4	0.39
Free Cash Flow per Basic Share	-0.34	-0.17	0.04	0.11	0.06	0.06	0.03	0.28	0.73	0.41	0.33	0.37	0.19	-0.24
Dividend per Share	0.15	0.19	0.1	0.15	0.11	0.17	0.14	0.13	0.16	0.17	0.16	0.3	0.3	0.3
Book Value per Share	0.64	0.64	0.91	1.06	1	1.51	1.73	2.08	2.56	2.8	3.34	3.58	3.64	3.8
Tangible Book Value per Share	1.49	1.44	1.46	2.58	2.34	1.73	2.07	2.48	4.12	4.26	4.81	5.12	5.19	5.38
Basic Weighted Avg Shares	775	757	773	799	914	898	913	912	917	989	989	988	993	989
Sales/Revenue/Turnover	1,992	2,315	2,471	2,480	2,504	2,853	3,622	3,709	4,019	4,357	4,380	4,123	4,001	3,971
Operating Margin (%)	10.02	5.43	5.59	7.31	8.19	13.31	14.58	17.03	17.05	16.61	17.18	15.96	17.67	17.81
Depreciation Expense	42	61	84	91	92	96	126	135	177	190	193	219	227	- -
Net Income, GAAP	121	61	57	107	146	207	301	410	505	619	749	563	397	390
Effective Tax Rate (%)	19.31	27.79	33.29	18.22	20.01	21.1	19.75	16.09	14.85	14.88	14.28	12.4	19.75	19.51
Profit Margin (%)	6.05	2.62	2.29	4.3	5.84	7.24	8.32	11.07	12.55	14.21	17.11	13.66	9.93	9.82
Working Capital	156	61	59	864	761	1,085	1,115	1,109	2,125	2,186	2,465	2,353	2,486	2,611
LT Debt	78	190	134	84	- -	1,090	1,071	960	588	321	198	48	31	36
Total Equity	1,203	1,182	1,228	2,153	2,237	2,386	2,710	3,059	4,582	4,950	5,507	5,830	5,888	6,073
Return on Invested Capital (%)	9.2	4.72	4.39	5.96	5.85	8.38	9.57	11.34	10.93	10.65	11.15	9.72	9.42	9.19
Return on Capital (%)	14.4	8.88	7.2	10.29	11.92	9.15	9.22	11.87	13.97	17.43	20.65	15.11	10.56	10.26
Return on Common Equity (%)	25.17	12.38	9.59	13.79	16.6	18.22	20.53	23.57	23.76	24.18	24.65	16.45	11.1	10.47

Capital Structure

•

in mil. unless spec.

Working Capital

•

in mil. unless spec.

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)	10 years	5 years	1 year
Sales/Revenue/Turnover	5.31%	1.7%	-2.98%
Net Income, GAAP	26.09%	2.48%	-29.46%
Free Cash Flow	109.8%	12.97%	-47.05%
Total Cash Common Dividend	19.93%	25.42%	-0.53%
Total Equity	18.83%	15.19%	1%

Growth Rates

•

in mil. unless spec.

Quarterly Revenue

•

in mil. unless spec.

Quarterly Earnings Per Share

•

in mil. unless spec.

Quarterly Dividends Per Share

•

in mil. unless spec.

Company Description

CEO: Mr. Weihua Jin
Full Time Employees: 3,281
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Address: No. 1 Xianyao Road Xianju People's Republic of China 317300
IPO Date: Jan 12, 2010
Website: xjpharma.com
Similar Companies: Red White & Bloom Brands Inc. (RWB.CN)
China Shineway Pharmaceutical Group Limited (CSWYY)
Venus Remedies Limited (VENUSREM.NS)
PPD, Inc. (PPD)
OrganiGram Holdings Inc. (OGI.TO)
Teva Pharmaceutical Industries Limited (TEVA)
Business: Zhejiang Xianju Pharmaceutical Co.,Ltd. manufactures and sells steroids and hormones worldwide. The company offers active pharmaceutical ingredients, such as steroid drugs, and male and female hormones; intermediates; and finished formulations in the form of tablets, capsules, granules, soft capsules, powder inhalations, creams, gels, injections, and powder-injections. Zhejiang Xianju Pharmaceutical Co.,Ltd. was founded in 1972 and is based in Xianju, China.

	Sep'24	Dec'24	Mar'25
Total Current Assets	3,199	3,264	3,328
Accounts Receivable, Net	675	562	669
Cash, Cash Equivalents & STI	1,299	1,382	1,363
Inventories	895	931	922
Total Current Liabilities	738	778	717
Payables & Accruals	- -	- -	- -
ST Debt	64	28	28
Deferred Revenue	- -	- -	- -

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	TTM
Revenue per Share	2.57	3.06	3.2	3.1	2.74	3.18	3.97	4.07	4.38	4.41	4.43	4.17	4.03	4.02
Basic EPS, GAAP	0.16	0.08	0.07	0.13	0.16	0.23	0.33	0.45	0.55	0.63	0.76	0.57	0.4	0.39
Free Cash Flow per Basic Share	-0.34	-0.17	0.04	0.11	0.06	0.06	0.03	0.28	0.73	0.41	0.33	0.37	0.19	-0.24
Dividend per Share	0.15	0.19	0.1	0.15	0.11	0.17	0.14	0.13	0.16	0.17	0.16	0.3	0.3	0.3
Book Value per Share	0.64	0.64	0.91	1.06	1	1.51	1.73	2.08	2.56	2.8	3.34	3.58	3.64	3.8
Tangible Book Value per Share	1.49	1.44	1.46	2.58	2.34	1.73	2.07	2.48	4.12	4.26	4.81	5.12	5.19	5.38
Basic Weighted Avg Shares	775	757	773	799	914	898	913	912	917	989	989	988	993	989
Sales/Revenue/Turnover	1,992	2,315	2,471	2,480	2,504	2,853	3,622	3,709	4,019	4,357	4,380	4,123	4,001	3,971
Operating Margin (%)	10.02	5.43	5.59	7.31	8.19	13.31	14.58	17.03	17.05	16.61	17.18	15.96	17.67	17.81
Depreciation Expense	42	61	84	91	92	96	126	135	177	190	193	219	227	- -
Net Income, GAAP	121	61	57	107	146	207	301	410	505	619	749	563	397	390
Effective Tax Rate (%)	19.31	27.79	33.29	18.22	20.01	21.1	19.75	16.09	14.85	14.88	14.28	12.4	19.75	19.51
Profit Margin (%)	6.05	2.62	2.29	4.3	5.84	7.24	8.32	11.07	12.55	14.21	17.11	13.66	9.93	9.82
Working Capital	156	61	59	864	761	1,085	1,115	1,109	2,125	2,186	2,465	2,353	2,486	2,611
LT Debt	78	190	134	84	- -	1,090	1,071	960	588	321	198	48	31	36
Total Equity	1,203	1,182	1,228	2,153	2,237	2,386	2,710	3,059	4,582	4,950	5,507	5,830	5,888	6,073
Return on Invested Capital (%)	9.2	4.72	4.39	5.96	5.85	8.38	9.57	11.34	10.93	10.65	11.15	9.72	9.42	9.19
Return on Capital (%)	14.4	8.88	7.2	10.29	11.92	9.15	9.22	11.87	13.97	17.43	20.65	15.11	10.56	10.26
Return on Common Equity (%)	25.17	12.38	9.59	13.79	16.6	18.22	20.53	23.57	23.76	24.18	24.65	16.45	11.1	10.47

Year	Q1	Q2	Q3	Q4	FY
2023	957	1,161	1,119	886	4,123
2024	1,038	1,100	1,099	764	4,001
2025	1,008	- -	- -	- -	- -

	Sep'24	Dec'24	Mar'25
ST Debt	64	28	28
LT Borrowings	37	20	23
LT Finance Leases	4	10	13
Preferred Equity and Hybrid Capital	- -	- -	- -
Shares Outstanding	989	989	989
Market Capitalization	13,352	9,831	9,879

Zhejiang Xianju Pharmaceutical Co.,Ltd.

Growth Rates

(avg. rate of change)

Company Description

Growth Rates

(avg. rate of change)

Working Capital

Quarterly Dividends Per Share

Year

Quarterly Revenue

Year

Quarterly Earnings Per Share

Year

Capital Structure